1,207
Views
0
CrossRef citations to date
0
Altmetric
Articles

Novel Therapies for Sleep Apnea—The Implants Have Arrived!

, MS, RPSGT, RST ORCID Icon & , M.D.
Pages 116-125 | Received 16 Nov 2017, Accepted 09 May 2018, Published online: 20 Jun 2018
 

ABSTRACT

Positive airway pressure (PAP) therapy has been the standard treatment of choice for sleep disordered breathing, with 29–83% of patients being noncompliant. With the advent of newly Food and Drug Adminisatration (FDA)-approved implantable stimulators for treating sleep disordered breathing in a fraction of noncompliant PAP therapy patients, the landscape of sleep medicine and sleep technology is changing to narrow the gap between compliant and non-compliant patients. The remedē® System for treating central sleep apnea and the Inspire® upper airway stimulation (UAS) therapy for treating obstructive sleep apnea are providing new tools for sleep physicians, elevating sleep technologists’ expertise, and paving the way for personalized medicine.

DISCLOSURE STATEMENT

EMV consulted for ReVENT Medical, Inc., and Nyxoah S.A.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.